Total Payments
$91,037
2024 Payments
$10,765
Companies
45
Transactions
526
Medicare Patients
9,086
Medicare Billing
$958,187
Payment Breakdown by Category
Consulting$48,300 (53.1%)
Other$16,200 (17.8%)
Travel$13,462 (14.8%)
Food & Beverage$12,801 (14.1%)
Education$273.69 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $48,300 | 11 | 53.1% |
| Travel and Lodging | $13,462 | 36 | 14.8% |
| Food and Beverage | $12,801 | 466 | 14.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,600 | 6 | 10.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,600 | 2 | 7.2% |
| Education | $273.69 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CVRx, Inc. | $54,555 | 54 | $0 (2024) |
| Amgen Inc. | $11,784 | 44 | $0 (2024) |
| ShockWave Medical, Inc | $8,825 | 24 | $0 (2024) |
| Boston Scientific Corporation | $6,235 | 26 | $0 (2024) |
| Cardiovascular Systems Inc. | $2,531 | 36 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $911.91 | 74 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $756.45 | 51 | $0 (2024) |
| Abbott Laboratories | $646.67 | 11 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $471.34 | 28 | $0 (2024) |
| Inari Medical, Inc. | $397.96 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,765 | 103 | ShockWave Medical, Inc ($8,388) |
| 2023 | $15,295 | 101 | CVRx, Inc. ($8,751) |
| 2022 | $10,954 | 119 | CVRx, Inc. ($8,962) |
| 2021 | $21,561 | 131 | CVRx, Inc. ($18,276) |
| 2020 | $830.51 | 23 | CVRx, Inc. ($254.74) |
| 2019 | $1,917 | 13 | Boston Scientific Corporation ($1,439) |
| 2018 | $22,841 | 18 | CVRx, Inc. ($17,836) |
| 2017 | $6,875 | 18 | Amgen Inc. ($6,359) |
All Payment Transactions
526 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Antibacterial Mesh | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Surgical Stapling | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/07/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Lithoplasty | ||||||
| 10/31/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $41.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: AVVIGO_IC | ||||||
| 10/22/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.52 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Not Applicable | ||||||
| 09/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $39.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | ShockWave Medical, Inc | Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher (Device) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Lithoplasty | ||||||
| 09/24/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Not Applicable | ||||||
| 09/23/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: AVVIGO_IC | ||||||
| 09/20/2024 | Bard Peripheral Vascular, Inc. | LUTONIX Drug Coated Balloon (Device) | Food and Beverage | In-kind items and services | $60.80 | General |
| Category: Vascular/Oncology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: Not Applicable | ||||||
| 08/25/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,900 | 3,639 | $1.1M | $273,410 |
| 2022 | 27 | 2,651 | 3,444 | $831,587 | $286,670 |
| 2021 | 29 | 2,661 | 4,366 | $862,932 | $307,118 |
| 2020 | 18 | 874 | 1,013 | $215,871 | $90,989 |
Total Patients
9,086
Total Services
12,462
Medicare Billing
$958,187
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 650 | 883 | $201,301 | $77,693 | 38.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 83 | 83 | $85,386 | $26,019 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 208 | 369 | $54,918 | $22,085 | 40.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 128 | 129 | $42,608 | $17,201 | 40.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 304 | 308 | $149,536 | $15,938 | 10.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 75 | 76 | $147,577 | $15,105 | 10.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 144 | 149 | $41,025 | $14,557 | 35.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 85 | 167 | $31,843 | $14,436 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 125 | 125 | $44,164 | $14,256 | 32.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 60 | 240 | $23,888 | $10,834 | 45.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 16 | 21 | $44,338 | $8,127 | 18.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 135 | 135 | $48,573 | $6,043 | 12.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 95 | $14,268 | $5,714 | 40.0% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $45,374 | $4,522 | 10.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $7,657 | $2,947 | 38.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 30 | 30 | $16,877 | $2,417 | 14.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 208 | 218 | $16,398 | $2,106 | 12.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 17 | 19 | $9,292 | $1,542 | 16.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 134 | 150 | $11,364 | $1,407 | 12.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 24 | 24 | $22,356 | $1,386 | 6.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 17 | 17 | $6,111 | $1,183 | 19.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 11 | 16 | $2,998 | $946.72 | 31.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 15 | $2,385 | $913.20 | 38.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 24 | 40 | $4,473 | $900.68 | 20.1% |
| 75716 | Review by radiologist of both arms or legs arteries image | Facility | 2023 | 12 | 12 | $6,104 | $832.56 | 13.6% |
About Dr. James Smith, M.D
Dr. James Smith, M.D is a Cardiovascular Disease healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1780023028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Smith, M.D has received a total of $91,037 in payments from pharmaceutical and medical device companies, with $10,765 received in 2024. These payments were reported across 526 transactions from 45 companies. The most common payment nature is "Consulting Fee" ($48,300).
As a Medicare-enrolled provider, Smith has provided services to 9,086 Medicare beneficiaries, totaling 12,462 services with total Medicare billing of $958,187. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Charleston, SC
- Active Since 06/20/2013
- Last Updated 06/05/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780023028
Products in Payments
- Barostim Neo System (Device) $54,555
- Repatha (Biological) $11,717
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $8,370
- AVVIGO Guidance System (Device) $4,506
- Diamondback Peripheral (Device) $1,622
- CROSSBOSS (Device) $1,439
- XARELTO (Drug) $911.91
- Diamondback Coronary (Device) $478.89
- LifeVest (Device) $471.34
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $437.52
- Peripheral Orbital Atherectomy System (Device) $429.52
- LEQVIO (Drug) $382.15
- ENTRESTO (Drug) $374.30
- JARDIANCE (Drug) $329.92
- ELIQUIS (Drug) $320.44
- Arcalyst (Drug) $250.15
- FLOWTRIEVER CATHETER, S (Device) $234.17
- DIAMONDBACK PERIPHERAL (Device) $232.00
- NEXLETOL (Drug) $193.18
- FlowTriever (Device) $163.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Charleston
Robert Biederman, Md, MD
Cardiovascular Disease — Payments: $1.0M
Cardiovascular Disease $1.0M
Jeffrey Winterfield, M.d, M.D
Cardiovascular Disease — Payments: $549,685
Cardiovascular Disease $549,685
Frank Cuoco, Md, MD
Cardiovascular Disease — Payments: $292,531
Cardiovascular Disease $292,531
Sarah Rinehart, Md, MD
Cardiovascular Disease — Payments: $198,204
Cardiovascular Disease $198,204
Daniel Judge, M.d, M.D
Cardiovascular Disease — Payments: $165,251
Cardiovascular Disease $165,251
Dr. Sheldon Litwin, M.d, M.D
Cardiovascular Disease — Payments: $153,640
Cardiovascular Disease $153,640